english.prescrire.org > Prescrire International > N°275 - November 2025

n°275

November 2025

Issue Contents
Editorial

Free  Drug residues in water: the pharmaceutical industry haggling over their removal

p.255

Marketing Authorisations


Gefapixant (Lyfnua°) in refractory or unexplained chronic cough

p.257-260

Editors' opinion. Anticipate

p.259

Etrasimod (Velsipity°) in ulcerative colitis

p.261-262

Aripiprazole 720 mg and 960 mg (Abilify Maintena°) for injection once every 2 months

p.262-263

Trivalent influenza vaccine produced in cell culture (Flucelvax°)

p.263

Bimekizumab (Bimzelx°) in hidradenitis suppurativa

p.264

Alectinib (Alecensa°) as adjuvant treatment for certain ALK-positive non-small cell lung cancers

p.265

Alectinib (Alecensa°) as first-line treatment in advanced or metastatic ALK-positive non-small cell lung cancer

p.266-267

Aztreonam + avibactam (Emblaveo°) in certain serious infections

p.267-268

Semaglutide (Wegovy°) in excess body weight

p.268-269

Finasteride in androgenetic alopecia: suicides, yet still not withdrawn from the market

p.270

Semaglutide in diabetes with chronic kidney disease: lower mortality

p.271

Ruxolitinib cream (Opzelura°): crystals with adverse effects

p.272

Adverse Effects


Drug-induced impulse control disorders: an insight into the devastating effects on patients' lives

p.273-274

Common stem: -pixant

p.274

NSAIDs in utero: chronic kidney disease in childhood

p.274

Drug-induced sexual dysfunction in women

p.275

Neuroleptics in children: tardive dyskinesia

p.275-276

Progestogens and meningioma: desogestrel, too

p.276

Outlook


Free  Clinical evaluation of medical devices: as of 2025, progress is difficult to ascertain and weaknesses persist

p.277-278

Minimal clinically important difference: a useful concept, but critical analysis required

p.278-279

Masthead


Free  Masthead

p.254

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe